# Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR

> **NCT03796104** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 100 (estimated)

## Conditions studied

- Bone and Joint Infection
- Staphylococcus Aureus

## Interventions

- **OTHER:** Delta-haemolysin

## Key facts

- **NCT ID:** NCT03796104
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796104, "Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03796104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*